Share Email Print
cover

Proceedings Paper

Imaging enhancement of malignancy by cyclophosphamide: surprising chemotherapy opposite effects
Author(s): Kensuke Yamauchi; Meng Yang; Katsuhiro Hayashi; Ping Jiang; Mingxu Xu; Norio Yamamoto; Hiroyuki Tsuchiya; Katsuro Tomita; A. R. Moossa; Michael Bouvet; Robert M. Hoffman
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Although side effects of cancer chemotherapy are well known, "opposite effects" of chemotherapy which enhance the malignancy of the treated cancer are not well understood. We have observed a number of steps of malignancy that are enhanced by chemotherapy pre-treatment of mice before transplantation of human tumor cells. The induction of intravascular proliferation, extravasation, and colony formation by cancer cells, critical steps of metastasis was enhanced by pretreatment of host mice with the commonly-used chemotherapy drug cyclophosphamide. Cyclophosphamide appears to interfere with a host process that inhibits intravascular proliferation, extravasation, and extravascular colony formation by at least some tumor cells. Cyclophosphamide does not directly affect the cancer cells since cyclophosphamide has been cleared by the time the cancer cells were injected. Without cyclophosphamide pretreatment, human colon cancer cells died quickly after injection in the portal vein of nude mice. Extensive clasmocytosis (destruction of the cytoplasm) of the cancer cells occurred within 6 hours. The number of apoptotic cells rapidly increased within the portal vein within 12 hours of injection. However, when the host mice were pretreated with cyclophosphamide, the cancer cells survived and formed colonies in the liver after portal vein injection. These results suggest that a cyclophosphamide-sensitive host cellular system attacked the cancer cells. This review describes an important unexpected "opposite effects" of chemotherapy that enhances critical steps in malignancy rather than inhibiting them, suggesting that certain current approaches to cancer chemotherapy should be modified.

Paper Details

Date Published: 29 February 2008
PDF: 5 pages
Proc. SPIE 6868, Small Animal Whole-Body Optical Imaging Based on Genetically Engineered Probes, 68680I (29 February 2008); doi: 10.1117/12.772085
Show Author Affiliations
Kensuke Yamauchi, Kanazawa Univ. School of Medicine (Japan)
Meng Yang, AntiCancer, Inc. (United States)
Katsuhiro Hayashi, Kanazawa Univ. School of Medicine (Japan)
AntiCancer, Inc. (United States)
Univ. of California, San Diego (United States)
Ping Jiang, AntiCancer, Inc. (United States)
Mingxu Xu, AntiCancer, Inc. (United States)
Norio Yamamoto, Kanazawa Univ. School of Medicine (Japan)
Hiroyuki Tsuchiya, Kanazawa Univ. School of Medicine (Japan)
Katsuro Tomita, Kanazawa Univ. School of Medicine (Japan)
A. R. Moossa, Univ. of California, San Diego (United States)
Michael Bouvet, Univ. of California, San Diego (United States)
Robert M. Hoffman, AntiCancer, Inc. (United States)
Univ. of California, San Diego (United States)


Published in SPIE Proceedings Vol. 6868:
Small Animal Whole-Body Optical Imaging Based on Genetically Engineered Probes
Alexander P. Savitsky; Robert E. Campbell; Robert M. Hoffman, Editor(s)

© SPIE. Terms of Use
Back to Top